Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease

NCT04346862 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

636

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Acetyl-L-carnitine hydrochloride 500mg
DRUG: Placebo

Sponsor

Hanmi Pharmaceutical Company Limited